• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唑类抗真菌药物的药物相互作用最新进展。

Update on drug interactions with azole antifungal agents.

作者信息

Lomaestro B M, Piatek M A

机构信息

Department of Pharmacy, Albany Medical Center, NY 12208, USA.

出版信息

Ann Pharmacother. 1998 Sep;32(9):915-28. doi: 10.1345/aph.17271.

DOI:10.1345/aph.17271
PMID:9762380
Abstract

OBJECTIVE

To review and update the incidence, mechanism, and clinical relevance of drug interactions with itraconazole, ketoconazole, and fluconazole.

DATA SOURCES

Literature was identified by MEDLINE search (from January 1990 to May 1997) using the name of each antifungal and the term "interaction" as MeSH headings. Abstracts were identified by literature citation and by review of Interscience Conference on Antimicrobial Agents and Chemotherapy from 1995 to 1996.

STUDY SELECTION

Randomized, controlled, double-blind studies were emphasized; however, uncontrolled studies and case reports were also included. In vitro data were selected from literature review and citations.

DATA EXTRACTION

Data were evaluated with respect to study design, clinical relevance, magnitude of interaction, and recommendations provided.

DATA SYNTHESIS

The incidence of fungal infections and consequent azole antifungal usage continues to increase. By virtue of their antifungal mechanism (i.e., inhibition of cytochrome P450 fungal enzyme systems), azoles have been investigated and implicated in several drug interactions. The magnitude of interactions can vary from trivial to potentially fatal, and also vary with specific azole and interactant.

CONCLUSIONS

The azole antifungal agents represent a commonly used class of agents with a broad range of potential interactions. Recent data have increased our understanding of drug--drug interactions with azoles. Pharmacists are in a unique position to identify these interactions and to intervene to decrease their morbidity and improve patient care.

摘要

目的

回顾并更新与伊曲康唑、酮康唑及氟康唑发生药物相互作用的发生率、机制及临床相关性。

资料来源

通过MEDLINE检索(1990年1月至1997年5月)确定文献,使用每种抗真菌药的名称及“相互作用”作为医学主题词。通过文献引用以及查阅1995年至1996年抗菌药物和化疗跨学科会议的资料确定摘要。

研究选择

重点强调随机、对照、双盲研究;但也纳入了非对照研究和病例报告。体外数据从文献综述及引用中选取。

资料提取

根据研究设计、临床相关性、相互作用程度及提供的建议对资料进行评估。

资料综合

真菌感染的发生率及随后唑类抗真菌药的使用持续增加。由于其抗真菌机制(即抑制细胞色素P450真菌酶系统),唑类已被研究并涉及多种药物相互作用。相互作用的程度可从轻微到潜在致命,且因特定的唑类及相互作用药物而异。

结论

唑类抗真菌药是一类常用药物,具有广泛的潜在相互作用。最新数据增进了我们对唑类药物-药物相互作用的理解。药剂师在识别这些相互作用并进行干预以降低其发病率及改善患者护理方面具有独特地位。

相似文献

1
Update on drug interactions with azole antifungal agents.唑类抗真菌药物的药物相互作用最新进展。
Ann Pharmacother. 1998 Sep;32(9):915-28. doi: 10.1345/aph.17271.
2
Management of drug and food interactions with azole antifungal agents in transplant recipients.移植受者中唑类抗真菌药物与药物和食物相互作用的管理。
Pharmacotherapy. 2010 Aug;30(8):842-54. doi: 10.1592/phco.30.8.842.
3
Azole antimycotics and drug interactions in the perioperative period.唑类抗真菌药物与围手术期的药物相互作用。
Curr Opin Anaesthesiol. 2010 Aug;23(4):441-8. doi: 10.1097/ACO.0b013e32833a254d.
4
Azole antifungal agents.唑类抗真菌剂。
Clin Infect Dis. 1992 Mar;14 Suppl 1:S161-9. doi: 10.1093/clinids/14.supplement_1.s161.
5
Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.潜在唑类药物相互作用的频率及氟康唑潜在药物相互作用的后果。
Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):755-67. doi: 10.1002/pds.1073.
6
Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.唑类疗法治疗皮肤利什曼病的疗效:一项系统评价和荟萃分析。
PLoS One. 2017 Oct 9;12(10):e0186117. doi: 10.1371/journal.pone.0186117. eCollection 2017.
7
Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.唑类抗真菌药物与其他共同给药药物的药代动力学相互作用的临床相关性。
Clin Infect Dis. 2009 May 15;48(10):1441-58. doi: 10.1086/598327.
8
Azole antifungals: 35 years of invasive fungal infection management.唑类抗真菌药物:侵袭性真菌感染管理的35年
Expert Rev Anti Infect Ther. 2015 Jun;13(6):787-98. doi: 10.1586/14787210.2015.1032939. Epub 2015 Apr 5.
9
Skin Allergy to Azole Antifungal Agents for Systemic Use: A Review of the Literature.全身性使用的唑类抗真菌药引起的皮肤过敏:文献综述
Recent Pat Inflamm Allergy Drug Discov. 2019;13(2):144-157. doi: 10.2174/1872213X13666190919162414.
10
Oral azole drugs as systemic antifungal therapy.口服唑类药物作为全身性抗真菌治疗。
N Engl J Med. 1994 Jan 27;330(4):263-72. doi: 10.1056/NEJM199401273300407.

引用本文的文献

1
biological activities of a combination of Ha-rak remedy, , and for the treatment of atopic dermatitis.哈拉克疗法、(此处原文缺失部分内容)以及(此处原文缺失部分内容)联合治疗特应性皮炎的生物活性。
Res Pharm Sci. 2025 Mar 31;20(2):250-267. doi: 10.4103/RPS.RPS_206_23. eCollection 2025 Apr.
2
Clinically Relevant Interactions with Anti-Infectives on Intensive Care Units-A Multicenter Delphi Study.重症监护病房中抗感染药物的临床相关相互作用——一项多中心德尔菲研究
Antibiotics (Basel). 2021 Oct 31;10(11):1330. doi: 10.3390/antibiotics10111330.
3
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.
抗真菌药物的药代动力学:优化患者治疗的实际意义。
Infection. 2017 Dec;45(6):737-779. doi: 10.1007/s15010-017-1042-z. Epub 2017 Jul 12.
4
Clinical and laboratory update on blastomycosis.关于球孢子菌病的临床和实验室最新进展。
Clin Microbiol Rev. 2010 Apr;23(2):367-81. doi: 10.1128/CMR.00056-09.
5
In search of the holy grail of antifungal therapy.寻找抗真菌治疗的圣杯。
Trans Am Clin Climatol Assoc. 2008;119:197-215; discussion 215-6.
6
Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects.酮康唑对健康受试者中罗格列酮药代动力学的影响。
Br J Clin Pharmacol. 2004 Oct;58(4):397-402. doi: 10.1111/j.1365-2125.2004.02161.x.
7
Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS.利福平对艾滋病患者氟康唑药代动力学的影响。
Clin Pharmacokinet. 2004;43(11):725-32. doi: 10.2165/00003088-200443110-00003.
8
5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide.5-羟色胺经细胞色素P450 2C9、2C19和2B6生物转化为羟胺,后者再转化为一氧化氮。
Br J Pharmacol. 2004 Feb;141(3):407-14. doi: 10.1038/sj.bjp.0705632. Epub 2004 Jan 12.
9
Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.选择用于门诊胃肠外抗菌治疗的抗菌药物:药代动力学-药效学考量
Clin Pharmacokinet. 2003;42(9):793-817. doi: 10.2165/00003088-200342090-00002.
10
Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes.伏立康唑对一名肝移植受者及人肝微粒体中他克莫司代谢的抑制作用。
Antimicrob Agents Chemother. 2002 Sep;46(9):3091-3. doi: 10.1128/AAC.46.9.3091-3093.2002.